Pharmaceutical Industry

IHMA Europe Sàrl 

Monthey · Since 2009

The core activity of International Health Management Associates (IHMA) is to support pharmaceutical companies in the development of medicines, particularly in the area of antimicrobial therapies. IHMA offers a wide range of services, including: * Drug Discovery: Identification and development of new medicines * Clinical Development: Conducting clinical trials and tests * Regulatory Submissions: Supporting the approval of medicines by regulatory authorities * Commercialization: Supporting the market launch and marketing of medicines IHMA has its own laboratories and uses modern technologies to deliver high-quality tests and data. The company works closely with healthcare institutions and pharmaceutical companies to enable successful drug developments.

InterAx Biotech AG 

Schlieren · Since 2016

The core activity of InterAx Biotech AG is the development of solutions in the field of computer-aided chemistry and systems biology, particularly in the context of GPCR signaling pathways and medicinal chemistry. The company combines expertise in computer science, biology, chemistry, and pharmacy to develop innovative approaches for the development of drugs and therapies.

IQONE HEALTHCARE SWITZERLAND SA 

Versoix · Since 2024

IQONE HEALTHCARE SWITZERLAND SA is a pharmaceutical company that supplies biosimilars and related services to healthcare professionals and patients. Its portfolio includes biosimilars for oncology, immunology and other therapeutic areas, and its services cover market-access support, logistics with local stock, commercial and medical support, training and patient information; the company is part of the Celltrion group.

Iscador AG 

Arlesheim · Since 2013

The core activity of Iscador AG is the manufacture and research of plant-based preparations for the integrative treatment of cancer diseases.

Labatec Pharma SA 

Meyrin · Since 1957

Labatec is a pharmaceutical company specializing in the development, manufacture and marketing of medicines and health products. The company's core activity is to provide quality products to the hospital sector and retail in various therapeutic areas, including skeletal diseases and women's health. The company offers both prescription and over-the-counter products and has a strong presence in the Middle East/North Africa (MENA) region and in Switzerland.

Maras AG 

Cham · Since 1989

The core activity of MARAS AG is to provide services in the areas of Regulatory Affairs, Quality Assurance and Pharmacovigilance for the Swiss and international pharmaceutical industry. Specifically, this includes support in the approval of medicinal products, quality assurance, drug safety, compliance, reimbursement and consulting and training of employees in the pharmaceutical industry.

Melisana AG 

Zurich · Since 1997

The core activity of Melisana AG is the marketing of over-the-counter medicinal products, dietary supplements and cosmetic products for self-medication, particularly in the Consumer Healthcare sector.

Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug 

Zug · Since 2024

The core activity of Mitsubishi Tanabe Pharma GmbH is the research, development and marketing of pharmaceuticals, particularly in the areas of autoimmune diseases, diabetes and kidney diseases. The focus is on marketing specific medications such as Argatra (Argatroban monohydrate) and RADICAVA (Edaravone) in Germany, Austria and Switzerland.

ND BioSciences SA 

Epalinges · Since 2019

ND BioSciences SA develops next-generation therapeutics and diagnostic assays for neurodegenerative diseases using validated and patented protein‑engineering and cellular drug‑discovery platforms. The company, a spin-off from the École polytechnique fédérale de Lausanne (EPFL), applies models that reproduce pathogenic protein aggregates and aggregation stages to support drug and biomarker development.

NMS Bio-Médical S.A. 

Le Mouret · Since 1996

The core activity of NMS Biomedical SA is the development, manufacture and distribution of medical products and devices, particularly in the fields of dermatology, gynecology and andrology. The company offers a wide range of products, including skin care products, medical devices for gynecology and andrology, as well as products for assisted reproductive technology (ART).

NovImmune SA 

Plan-Les-Ouates · Since 1998

The core activity of NovImmune SA is the development of antibodies, in particular natural bispecific antibodies (κλ-bodies), for the treatment of cancer. The company focuses on the development of therapeutics that specifically target tumor cells by targeting specific molecules such as CD47 and CD28.

NUTRICRAFT SA 

Collombey · Since 2025

NUTRICRAFT SA is a production laboratory specializing in the development and contract manufacture of dietary supplements and nutraceutical products. The company provides formulation and sourcing, capsule/tablet/liquid production, packaging and repackaging, quality control including microbiological analyses, logistics and storage, research and development, and label/marketing services.

Ophtapharm AG 

Hettlingen · Since 2003

The core activity of Ophtapharm AG is the manufacture of sterile eye and ear products, particularly liquid and semi-solid dosage forms such as drops, suspensions, gels and ointments. The company offers contract manufacturing services, where it develops, manufactures and packages products for its customers. The products are mainly sold on the American market and distributed worldwide by the company's customers.

Peptone Switzerland AG 

Bellinzona · Since 2024

The core activity of Peptone is the development of small molecules for targeted treatment of intrinsically disordered proteins (IDPs) using Artificial Intelligence (AI) and experimental physics. The company focuses on the discovery and development of drugs that specifically target these proteins, which are responsible for many diseases.

PharmaS Switzerland SA 

Versoix · Since 2014

PharmaS Switzerland SA provides biosimilars to healthcare professionals and patients in Switzerland and offers a portfolio covering therapeutic areas such as oncology, inflammatory diseases and gastroenterology. The company supplies local services including inventory and logistics, medical information, training and support for market access and partnering.

Phylak Sachsen (Schweiz) GmbH 

Lützelflüh-Goldbach · Since 1997

Phylak Sachsen (Schweiz) GmbH produces spagyric medicinal products according to Dr. Zimpel's method and provides professional training for physicians, pharmacists and naturopaths. Its portfolio includes plant essences and cosmetic products; manufacturing is subject to GMP quality controls and distribution takes place via pharmacies in several countries.

RECORDATI AG 

Basel · Since 2025

RECORDATI AG sells proprietary and under-licence pharmaceuticals across several therapeutic areas, primarily prescription medicines (Rx, OTx). The company's core expertise and commitments focus on cardiology, urology (including benign prostatic hyperplasia) and schizophrenia.

ROSE PHARMA SA 

Lugano · Since 2007

The core activity of Rose Pharma is the development, manufacture and distribution of hyaluronic acid-based fillers for aesthetic medicine, particularly for facial rejuvenation, skin rehydration, gynaecological rejuvenation and the treatment of joint diseases.

Sandoz AG 

Basel · Since 1979

The core activity of Sandoz is the development, manufacture and marketing of generics and biosimilars, particularly in the field of pharmaceuticals.

Swiss Plasmabiotech GmbH 

Schwerzenbach · Since 2018

Swiss Plasmabiotech GmbH is a biotechnology company that develops, manufactures and distributes patented SPB PRP products for autologous blood plasma therapy. Its product range includes certified SPB PRP tubes (class IIa medical devices), centrifuges, accessory kits and exosome-based skincare products for medical and aesthetic applications.